The metabolic switch of cancer : From the 2016 Sino-US Symposium on Cancer Metabolism, Chongqing, P.R. China, October 10–11, 2016

Yuting Ma,Xuemei Tong,Yong Liao

DOI: https://doi.org/10.1016/j.gendis.2017.02.002

IF: 7.376

2017-01-01

Genes & Diseases

Abstract:Although remarkable progress has been made in oncology research, cancer is still a leading cause of death worldwide. It is well recognized that cancer is a genetic disease, yet metabolic alterations or reprogramming are the major phenotypes associated with the (epi-)genetic modifications of cancer cells. Thus, understanding the metabolic changes of tumor cells will facilitate the diagnosis of cancer, alleviate drug resistance and provide novel druggable targets that can lead to cures for cancer. The first Sino-US Symposium on Cancer Metabolism was held in Chongqing on October 10th and 11th, with the theme of “cancer metabolism and precision cancer therapy”. The symposium brought about a dozen keynote speakers each from the US and mainland China, as well as one hundred delegates with an interest in cancer metabolism. This short article will briefly summarize the advances reported during this meeting.